Philadelphia Trust CO Regenerx Biopharmaceuticals Inc Transaction History

Philadelphia Trust CO

  • $1.29 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 08, 2019
SELL
$0.17 - $0.24 $292 - $413
-1,721 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$0.1 - $0.35 $14,827 - $51,897
-148,279 Reduced 98.85%
1,721 $707,000
Q4 2018

Feb 13, 2019
BUY
$0.09 - $0.2 $13,500 - $30,000
150,000 New
150,000 $23,000

About REGENERX BIOPHARMACEUTICALS INC

RGRX Quotes by TradingView
  • Ticker RGRX
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,550,000
  • Description
  • RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; ...
More about RGRX
Track This Portfolio

Track Philadelphia Trust CO Portfolio

Follow Philadelphia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email